Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction (Version 3: Revised May 20th, 2024)
Crossref DOI link: https://doi.org/10.1007/s10157-024-02607-2
Published Online: 2025-01-03
Published Print: 2025-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Text and Data Mining valid from 2025-01-03
Version of Record valid from 2025-01-03
Article History
Accepted: 25 November 2024
First Online: 3 January 2025